At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 71 enrolled
Drug / intervention
BI 695501 prefilled syringe +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Single-dose, Parallel-arm, Open-label Phase I Trial to Investigate and Compare the Pharmacokinetics, Safety and Tolerability of BI 695501 Administered Subcutaneously Via Prefilled Syringe or Autoinjector
In Brief
A Phase 1 clinical trial evaluating BI 695501 prefilled syringe and BI 695501 autoinjector for Healthy. Completed, enrolled 71 participants across 1 site.
Detailed Summary
To investigate and compare the pharmacokinetics, safety and tolerability of BI 695501 administered subcutaneously via prefilled syringe or autoinjector
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesBelgium
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartOct 2015
First PostedNov 2015
Primary CompletionSep 2016
Study CompletionOct 2016
TodayJul 2026
First PostedNov 17, 2015
Enrollment StartOct 28, 2015
Primary CompletionSep 7, 2016
Study CompletionOct 4, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 10.6 years ago
Interventions
BI 695501 prefilled syringedrug
BI 695501 autoinjectordrug